Cargando…

Fixed‐dose combinations of drugs versus single‐drug formulations for treating pulmonary tuberculosis

BACKGROUND: People who are newly diagnosed with pulmonary tuberculosis (TB) typically receive a standard first‐line treatment regimen that consists of two months of isoniazid, rifampicin, pyrazinamide, and ethambutol followed by four months of isoniazid and rifampicin. Fixed‐dose combinations (FDCs)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gallardo, Carmen R, Rigau Comas, David, Valderrama Rodríguez, Angélica, Roqué i Figuls, Marta, Parker, Lucy Anne, Caylà, Joan, Bonfill Cosp, Xavier
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Ltd 2016
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4916937/ https://www.ncbi.nlm.nih.gov/pubmed/27186634 http://dx.doi.org/10.1002/14651858.CD009913.pub2

Ejemplares similares

How oral health care organizations formulate actionable statements to inform practice and policy: A protocol for a systematic survey
por: Verdugo-Paiva, Francisca, et al.
Publicado: (2023)

Treating Tuberculosis: Time to Introduce Fixed-Dose Drug Combinations
por: Manikandan, S
Publicado: (2012)

Anticancer Drugs Compared to No Anticancer Drugs in Patients with Advanced Hepatobiliary Cancer: A Mapping Review and Evidence Gap Map
por: Requeijo, Carolina, et al.
Publicado: (2023)

Sexual Function in Women with Breast Cancer: An Evidence Map of Observational Studies
por: Rodrigues-Machado, Nelson, et al.
Publicado: (2022)

Pharmacokinetic non-interaction analysis in a fixed-dose formulation in combination of atorvastatin and ezetimibe
por: Patiño-Rodríguez, Omar, et al.
Publicado: (2014)

Development of quality of care indicators from systematic reviews: the case of hospital delivery
por: Bonfill, Xavier, et al.
Publicado: (2013)

Comparison of the safety and efficacy of a fixed-dose combination regimen and separate formulations for pulmonary tuberculosis treatment
por: Wu, Jiun-Ting, et al.
Publicado: (2015)

Treating More with Less: Effectiveness and Event Outcomes of Antituberculosis Fixed-dose Combination Drug versus Separate-drug Formulation (Ethambutol, Isoniazid, Rifampicin and Pyrazinamide) for Pulmonary Tuberculosis Patients in Real-world Clinical Practice
por: Lai, Jacqueline Mui Lan, et al.
Publicado: (2019)

Too bad! Fixed dose combination antiretroviral drugs
por: Agyarko-Poku, Thomas, et al.
Publicado: (2014)

Fixed dose drug combinations: Issues and challenges in India
por: Gupta, Yogendra Kumar, et al.
Publicado: (2016)

Evidence mapping and quality assessment of systematic reviews on therapeutic interventions for oral cancer
por: Madera Anaya, Meisser, et al.
Publicado: (2018)

Pediatric dosing errors due to variable drug formulations
por: Mehndiratta, Sumit
Publicado: (2014)

Antenatal corticosteroids: a reappraisal of the drug formulation and dose
por: Jobe, Alan H., et al.
Publicado: (2020)

Consideration of sex and gender in Cochrane reviews of interventions for preventing healthcare-associated infections: a methodology study
por: López-Alcalde, Jesús, et al.
Publicado: (2019)

The bioequivalence of fixed‐dose combination tablets of bisoprolol and ramipril and its drug‐drug interaction potential
por: Sus, Jan, et al.
Publicado: (2021)

Fixed Drug Eruptions With Flavoured Liquid Formulations of Over-the-Counter Analgesics: A Case Report
por: Alzahrani, Ali H
Publicado: (2023)

A Fixed-Dose Combination of Ofloxacin-Ornidazole Induced Fixed Drug Eruption: A Case Report
por: Sarkar, Manuj K, et al.
Publicado: (2023)

Absence of a significant pharmacokinetic interaction between atorvastatin and fenofibrate: a randomized, crossover, study of a fixed-dose formulation in healthy Mexican subjects
por: Patiño-Rodríguez, Omar, et al.
Publicado: (2015)

Irrational fixed dose combinations of psychotropic drugs in India: Cause of concern
por: Solanki, Madhusudan Singh, et al.
Publicado: (2016)

Fixed drug eruption
por: Chou, Yu-Ju, et al.
Publicado: (2022)

Efficacy and safety of a four-drug fixed-dose combination regimen versus separate drugs for treatment of pulmonary tuberculosis: a systematic review and meta-analysis
por: Lima, Glaura C., et al.
Publicado: (2016)

Treatment outcomes and associated factors among patients with drug-sensitive tuberculosis on daily fixed-dose combination drugs: A cohort study from Ahmedabad, India
por: Prajapati, Arpit C., et al.
Publicado: (2023)

Pharmacokinetics of First-Line Drugs in Children With Tuberculosis, Using World Health Organization–Recommended Weight Band Doses and Formulations
por: Chabala, Chishala, et al.
Publicado: (2021)

Pharmacologic rationale, efficacy and safety of the fixed-dose co-formulation of indacaterol and glycopyrronium
por: Pelaia, Girolamo, et al.
Publicado: (2014)

Prevalence study of intermittent hormonal therapy of Prostate Cancer patients in Spain
por: Bonfill-Cosp, Xavier, et al.
Publicado: (2022)

Effects of a Fixed-Dose Co-Formulation of Daclatasvir, Asunaprevir, and Beclabuvir on the Pharmacokinetics of a Cocktail of Cytochrome P450 and Drug Transporter Substrates in Healthy Subjects
por: Garimella, Tushar, et al.
Publicado: (2017)

Fixed drug eruptions with modafinil
por: Ghoshal, Loknath, et al.
Publicado: (2015)

Fixed drug eruption to sitagliptin
por: Gupta, Mrinal, et al.
Publicado: (2015)

Fixed Drug Eruption to Hydroxychloroquine
por: Swarnkar, Bhavya, et al.
Publicado: (2021)

Fixed-dose combination associated with faster time to smear conversion compared to separate tablets of anti-tuberculosis drugs in patients with poorly controlled diabetes and pulmonary tuberculosis in Qatar
por: Al-Shaer, Mohammad H., et al.
Publicado: (2018)

Real-world impact of the fixed-dose combination on improving treatment outcomes of drug-susceptible tuberculosis: a comparative study using multiyear national tuberculosis patient data
por: Ki, Min Seo, et al.
Publicado: (2023)

Formulation and Optimization of Monolithic Fixed-Dose Combination of Metformin HCl and Glibenclamide Orodispersible Tablets
por: Belayneh, Anteneh, et al.
Publicado: (2020)

Bioequivalence and Food Effect Assessment of 2 Fixed‐Dose Combination Formulations of Dolutegravir and Lamivudine
por: Dumitrescu, Teodora Pene, et al.
Publicado: (2019)

Spotlight on Calcipotriol/Betamethasone Fixed-Dose Combination in Topical Formulations: Is There Still Room for Innovation?
por: Selmin, Francesca, et al.
Publicado: (2022)

Drug–Drug Compatibility Evaluation of Sulfasalazine and Folic Acid for Fixed-Dose Combination Development Using Various Analytical Tools
por: Jeličić, Mario-Livio, et al.
Publicado: (2021)

Examination of Haematotoxicity of Fixed-Dose Highly Active Antiretroviral Drug in Albino Wistar Rats
por: Nubila, Thomas, et al.
Publicado: (2012)

Rational approaches to the treatment of hypertension: drug therapy—monotherapy, combination, or fixed-dose combination?
por: Canbakan, Başol
Publicado: (2013)

Quality assurance of rifampicin-containing fixed-drug combinations in South Africa: dosing implications
por: Court, R., et al.
Publicado: (2018)

A Review of Fixed Drug Eruption with a Special Focus on Generalized Bullous Fixed Drug Eruption
por: Anderson, Hannah J., et al.
Publicado: (2021)

Cross sectional study of factors associated to self-reported blood-borne infections among drug users
por: Reyes-Urueña, Juliana, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_kp0ca6dvgeu52inp5gqcvefoq8